Drugs & Devices

By Jordan Paradise
In Conflicts of Interest
Dec 11th, 2014
0 Comments
By Jordan Paradise This week, the New York Times reported that ophthalmologists who were paid to promote Genentech’s drug Lucentis (ranibizumab) were among the top billers of the drug to federal programs, exceeding the prescribing amounts of more than 75% of their peers.  Lucentis, approved in 2006 by the Food and Drug Administration (FDA), is indicated […]...
By Kate Greenwood
In Bioethics
Nov 25th, 2014
0 Comments
By Carl H. Coleman Cross-Posted at Bill of Health With well over 5,000 global deaths from Ebola already reported, drug developers are working fast to begin human clinical trials of promising experimental treatments.  Earlier this month, US government officials announced plans to launch a study of multiple Ebola interventions at the NIH Clinical Center, Emory […]...
By Kate Greenwood
In Drugs & Devices
Nov 6th, 2014
1 Comment
By Nicole Stuver Three-dimensional scanning, modeling, and printing have become an emerging field of diagnosing and treating maladies.  This technology has enabled advances in neurology, dentistry, orthodontics, orthopedics, cardiology, oncology and other fields of practice.  These new technologies are revolutionary particularly because they have the capability to be c...
By Kate Greenwood
In Drugs & Devices
Oct 30th, 2014
0 Comments
Cross-Posted at Bill of Health As I have blogged about before, last year, in Kaiser v. Pfizer, the First Circuit joined the handful of courts to have approved a causal chain of injury running from a pharmaceutical company’s fraudulent promotion, through the prescribing decisions of thousands of individual physicians, to the prescriptions for which a third-party [&helli...
By Kate Greenwood
In Drugs & Devices
Oct 27th, 2014
0 Comments
It’s Monday morning, time for our Monday Morning Recap, the post where we call out recent drug and device law and policy developments that caught our eye and made us think. 1. Seton Hall Law School’s Kathleen Boozang appeared on Bloomberg Radio this past week, discussing pending litigation brought by the Kentucky Attorney General against […]...